drugset / Trial / NCT00966745

Milrinone During Living Donor Hepatectomy

NCT00966745

Completed 38 enrolled Seoul National University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Maintaining a low central venous pressure during living donor hepatectomy is routine practice. The investigators tried to test the hypothesis that using milrinone to maintain a low central venous pressure (CVP) during is associated with a superior surgical field and less blood loss.

Timeline

Start
2008-01
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milrinone Small molecule

Indications

No indication recorded.